益生菌在妇瘤患者急性放射性肠炎发生中的预防价值-现代医学

益生菌在妇瘤患者急性放射性肠炎发生中的预防价值

单位：康复大学青岛医院/青岛市市立医院肿瘤科, 山东青岛 266071

分类号：R730.55

出版年·卷·期（页码）：2023·51·第六期（765-769）

摘要：

目的：探讨在盆腔放疗中益生菌对急性放射性肠炎(ARE)的预防作用。方法:收集行盆腔放疗的妇瘤患者96例，随机分为观察组48例和对照组48例，观察组在放疗第1天开始服用益生菌(双歧杆菌三联活菌胶囊)直至放疗结束，对照组不预防应用益生菌，比较两组放疗期间ARE发生率的差异；放疗结束时进行炎症性肠病生活质量(IBDQ)评分；所有患者均在放疗前1天和放疗15次时分别留取血清进行检测，通过ELISA方法检测肿瘤坏死因子α(TNFα)及白介素8(IL-8)的表达水平；通过Logistic回归分析，明确发生ARE的影响因素。结果：观察组ARE的发生率低于对照组(52.1% vs. 72.9%，P<0.05)；通过IBDQ评分对比，观察组在生活质量方面显著优于对照组，尤其是在肠道症状、全身症状两方面获益明显；发生ARE的患者TNFα及IL-8的表达显著升高；经过Logistic多因素回归分析，影响ARE发生的因素依次为同步化疗、术后状态、应用益生菌、病种及肿瘤分期。结论：预防性应用益生菌可以有效降低ARE的发生率，改善放疗期间患者的生活质量。

Objective: To explore the preventive effect of probiotics on acute radiation enteritis(ARE) in pelvic radiotherapy. Methods: 96 cases of gynecological tumor patients undergoing pelvic radiotherapy were collected and randomly divided into observation group(48 cases) and control group(48 cases). The observation group patients took probiotics(bifidobacterium triple viable capsule) during radiotherapy, and the control group did not use probiotics. The incidence of ARE of two groups were compared; The Inflammatory Bowel Disease Questionnaire(IBDQ) was scored at the end of radiotherapy; Patients' serum were collected at the day before radiotherapy and 15 times of radiotherapy, and the contents of TNFα and IL-8 were detected by Elisa. Logistic regression analysis was conducted to identify the influencing factors of ARE. Results: The incidence rate of ARE in the observation group was significantly lower than that in the control group(52.1% vs. 72.9%, P<0.05). By comparing the IBDQ scores, the observation group was significantly better than the control group in quality of life, especially in terms of intestinal symptoms and systemic symptoms; The expressions of TNFα and IL-8 in patients of ARE were significantly increased. Logistic analysis showed that the influencing factors of ARE were synchronous chemotherapy, postoperative status, probiotic, disease type, and stage. Conclusion: Probiotics can effectively prevent the occurrence of ARE and improve the quality of life of patients during radiotherapy.

参考文献：

[1] LU L,LI W,CHEN L,et al.Radiation-induced intestinal damage:latest molecular and clinical developments[J].Future Oncol,2019,15(35):4105-4118.
[2] BAI J,BARANDOUZI Z A,ROWCLIFFE C,et al.Gut microbiome and its associations with acute and chronic gastrointestinal toxicities in cancer patients with pelvic radiation therapy:a systematic review[J].Front Oncol,2021,6(11):745262.
[3] CIORBA M A,STENSON W F.Probiotic therapy in radiation-induced intestinal injury and repair[J].Ann N Y Acad Sci,2009,1165:190-194.
[4] DELIA P,SANSOTTA G,DONATO V,et al.Prevention of radiation-induced diarrhea with the use of VSL#3,a new high-potency probiotic preparation[J].Am J Gastroenterol,2002,97(8):2150-2152.
[5] 中国医师协会外科医师分会,中华医学会外科学分会结直肠外科学组.中国放射性直肠炎诊治专家共识(2018 版)[J].中华胃肠外科杂志,2018,21(12):1321.
[6] GUYATT G,MITCHELL A,IRVINE E J,et al.A new measure of health status for clinical trials in inflammatory bowel disease[J].Gastroenterology,1989,96(3):804-810.
[7] FAN J,LIN B,FAN M,et al.Research progress on the mechanism of radiation enteritis[J].Front Oncol,2022,5(12):888962.
[8] WANG L,WANG X,ZHANG G,et al The impact of pelvic radiotherapy on the gut microbiome and its role in radiation-induced diarrhoea:a systematic review[J].Radiat Oncol,2021,25,16(1):187.
[9] 朱小月,江柯炜,陈海娇,等.盆腔恶性肿瘤患者放疗后肠道菌群变化与放射性肠炎的相关性研究[J].东南大学学报(医学版),2022,41(3):364-371.
[10] WANG Z,WANG Q,WANG X,et al.Gut microbial dysbiosis is associated with development and progression of radiation enteritis during pelvic radiotherapy[J].J Cell Mol Med,2019,23(5):3747-3756.
[11] JIAN Y,ZHANG D,LIU M,et al.The impact of gut microbiota on radiation-induced enteritis[J].Front Cell Infect Microbiol,2021,29(11):586392.
[12] HALLORAN K,UNDERWOOD M A.Probiotic mechanisms of action[J].Early Hum Dev,2019,135:58-65.
[13] DING X,LI Q,LI P,et al.Fecal microbiota transplantation:a promising treatment for radiation enteritis?[J].Radiother Oncol,2020,143:12-18.
[14] AHREN I L,BJURBERG M,STEINECK G,et al.Decreasing the adverse effects in pelvic radiation therapy:a randomized controlled trial evaluating the use of probiotics[J].Adv Radiat Oncol,2022,8(1):101089.
[15] KUMAGAI T,RAHMAN F,SMITH A M.The microbiome and radiation induced-bowel injury:evidence for potential mechanistic role in disease[J].Pathogenesis Nutrients,2018,10(10):1405.
[16] WARDILL H R,VAN SEBILLE Y Z A,CIORBA M A,et al.Prophylactic probiotics for cancer therapy-induced diarrhoea:a meta-analysis[J].Curr Opin Support Palliat Care,2018,12(2):187-197.
[17] ROY S,SALERNO K E,CITRIN D E.Biology of radiation-induced lung injury[J].Semin Radiat Oncol,2021,31(2):155-161.
[18] EOM K Y,WEE C W,SONG C,et al.The association between diarrhea and serum cytokines in patients with gynecologic cancer treated with surgery and pelvic chemoradiotherapy[J].Clin Transl Radiat Oncol,2021,29:60-64.
[19] MA C Y,ZHAO J,GAN G H,et al.Establishment of a prediction model for severe acute radiation enteritis associated with cervical cancer radiotherapy[J].World J Gastroenterol,2023,29(8):1344-1358.

服务与反馈：

【文章下载】【发表评论】【查看评论】【加入收藏】

提示：您还未登录，请登录！点此登录